Skip to content

Effects of lodhrasava and surasadi basti in patients of prameha

â??Management Of Santrpanottha Prameha(Type 2 Diabetes Mellitus ) With Lodhrasava And With And Without Surasadi Basti â?? An Open Labelled Randomized Comparative Clinical Trial.â??

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/01/017151
Enrollment
30
Registered
2019-01-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Surasadi niruha basti: Sursadi Niruha Basti will be made as described in Sushruta Samhita madhu 120 ml saindhav 10 gm surasadi tail 60 ml shunthyadi kalk 40 gm surasadi kwath 250 ml tot

Sponsors

Govtakhandanand ayurved college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Classical signs and symptoms of Santarpanottha prameha described in Ayurvedic classics as well as modern science Patient having classical signs and symptoms of the diasease as per Ayurveda as well as modern science like Avila Mutrata (turbidity)Prabhuta mutrata Mutra Madhuryata (glycosuria) Pipasa Adhikya Kshudha Adhikya Swedadhikya (perspiration) Angagandha (bad odour) Nidra Adhikya Kara Pada Suptata Hasta Pada Tala Daha Patients of Prameha having BMI >=25 to =126 mg/dl or P.P.B.S. >= 200mg/dl Age group of 32 to 70 years Diabetes chronicity

Exclusion criteria

Exclusion criteria: Patients of Prameha having BMI 35 Patients of Type-1 Diabetes or the patients of Type-2 Diabetes taking Insulin Patients having history of any major complications of Diabetes like Nephropathy Retinopathy Diabetic Foot Carbuncles etc Age 70 years Patients having history of Diabetes in association with other endocrinopathies like Hyperthyroidism etc Patients having history of drug or chemical induced Type-II Diabetes like glucocorticoids induced or thyroid hormone induced etc Patients having history of any Cardiovascular diseases Renal diseases or any other disease effecting multiple body systems and pregnant women etc

Design outcomes

Primary

MeasureTime frame
Result will be assessed on the basis of sign and symptoms of DIABETES MELLITUS and objective criteria.Timepoint: 17 days

Secondary

MeasureTime frame
Result will be assessed on the basis of sign and symptoms of diabetes mellitus objective criteriaTimepoint: 17 days

Countries

India

Contacts

Public ContactUrmi italia

Akhandanand ayurved college

Sweetyruparel@gmail.com9429202048

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026